Story
Aon Second-Quarter Profit Climbs on Strength in Commercial Risk Unit

Summary
The insurance brokerage reported a 5% rise in its key commercial risk solutions division, benefiting from strong demand in the construction sector fueled by data center projects.
Aon PLC reported a jump in second-quarter profit, driven by robust performance in its Commercial Risk Solutions segment as demand for specialized insurance offerings surged.
Adjusted net income attributable to shareholders for the three months ended June 30 rose to $814 million, or $3.81 per share, up from $759 million, or $3.49 per share, in the same period a year earlier, the company announced Wednesday.
Key Drivers and Segment Performance
The company's Commercial Risk Solutions arm was a standout performer, with revenue increasing 5% to $2.3 billion. Aon attributed this growth to strong demand from the construction industry, which saw double-digit growth in North America. This trend is being fueled by significant spending on data centers by large technology firms, which require complex insurance products for capital-intensive projects.
In its report, Aon noted it has been strategically increasing its hiring in high-growth areas such as data centers, construction, and energy to capitalize on these market trends and drive new business.
AdFinancial Metrics and Outlook
Aon's organic revenue, a key metric for the industry that strips out the effects of acquisitions and currency fluctuations, grew by 5% in the quarter. The company's role as an intermediary between clients and insurance carriers allows it to earn commissions on premiums, benefiting from rising demand and complex risk environments.
Looking ahead, Aon reaffirmed its full-year financial forecast, expecting annual revenue growth of mid-single digits or higher. "As clients navigate increasing complexity, we are expanding our addressable market, creating new opportunities with both traditional and non-traditional sources of capital," CEO Greg Case said in a statement.
Read next
More on Stocks
Iovance Biotherapeutics Lifts 2026 Revenue Outlook, Shares Jump
The biotechnology firm raised its full-year revenue guidance to between $410 million and $420 million, beating analyst estimates and citing strong demand for its cancer therapies.

JPMorgan Downgrades Monday.com to Neutral on Slowing Customer Growth
The investment bank lowered its rating on the work management software company, citing a decline in new recurring revenue and longer sales cycles among smaller businesses.

Insider Transactions: Meta, CrowdStrike CEOs Sell Stock; Executives Buy into REITs and Biotechs
Recent SEC filings show multi-million dollar stock sales by executives at Meta and CrowdStrike, mostly under pre-set plans, while leaders at Angel Oak Mortgage REIT and Inhibrx Biosciences made significant open-market purchases.

Plug Power Shares Rise on 280 MW Electrolyzer Deal for Danish Green Fuel Project
Plug Power has secured a major agreement to supply 280 MW of electrolyzers to Arcadia eFuels for a sustainable aviation fuel project in Denmark, causing its stock to climb in premarket trading.